Indium in-111 Pentetate Disodium: uses, dosing, side effects & brands
Indium in-111 Pentetate Disodium is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Solution
- Sold as
- Mpi Indium Dtpa in 111
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
How indium in-111 pentetate disodium is dosed
From the FDA label for Mpi Indium Dtpa in 111 (application NDA017707). Other indium in-111 pentetate disodium products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
Extreme care must be exercised to assure aseptic conditions in intrathecal injections. The maximum recommended intrathecal dose in the average patient (70 kg) is 18.5 MBq, 500 µ Ci. The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
Indium in-111 Pentetate Disodium side effects
Aseptic meningitis and pyrogenic reactions have been rarely (less than 0.4%) observed following cisternography with Pentetate lndium Disodium In 111. One death has been reported to have occurred within 20 minutes following the administration of Pentetate Indium Disodium In 111 and appears to be drug related. In addition, two cases of septic meningitis have also been reported. There have also been reports of skin reactions and vomiting following administration of Pentetate lndium Disodium In 111. Relationship of the drug to these latter occurrences has not been established.
Who shouldn’t take indium in-111 pentetate disodium
None known.
Every indium in-111 pentetate disodium product we track (1)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
Only one: Mpi Indium Dtpa in 111.
Related calculators
Frequently asked questions
What is indium in-111 pentetate disodium?
GE Healthcare (Medi-Physics, Inc.) Indium DTPA In 111 is a diagnostic drug for intrathecal use. It is available as a sterile, pyrogen-free, isotonic, aqueous solution, buffered to pH 7 to 8. At calibration time, each milliliter contains 37 MBq, 1 mCi of Pentetate Indium Disodium In 111 (no-carrier-added), 20 to 50 µ g of pentetic acid, and sodium bicarbonate for pH adjustment. The drug is to be discarded after single use. Radionuclidic purity at calibration time is at least 99.88% with less than 0.06% Indium In 114m and 0.06% Zinc Zn 65. The concentration of each radionuclidic contaminant changes with time. Graph 1 shows maximum concentration of each radionuclidic impurity as a function of time.
Can you take indium in-111 pentetate disodium with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run indium in-111 pentetate disodium against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What forms does indium in-111 pentetate disodium come in?
Across the brands we track, indium in-111 pentetate disodium is currently marketed as solution, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic indium in-111 pentetate disodium?
We do not currently list a generic-labelled indium in-111 pentetate disodium product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Indium in-111 Pentetate Disodium: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/indium-in-111-pentetate-disodium
- MLA
- “Indium in-111 Pentetate Disodium: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/indium-in-111-pentetate-disodium.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for indium in-111 pentetate disodium on DailyMed (NIH) ↗.